Trust Point Inc. Celcuity Inc. Transaction History
Trust Point Inc.
- $1.25 Trillion
- Q2 2024
A detailed history of Trust Point Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Trust Point Inc. holds 18,821 shares of CELC stock, worth $283,444. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,821
Previous 19,395
2.96%
Holding current value
$283,444
Previous $419 Million
26.41%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CELC
# of Institutions
93Shares Held
30.1MCall Options Held
4.8KPut Options Held
126K-
Bvf Inc San Francisco, CA3.47MShares$52.2 Million1.74% of portfolio
-
Morgan Stanley New York, NY2.84MShares$42.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$35.6 Million1.12% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$28.2 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$23.6 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $225M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...